Health Equity in Clinical Trials Congress | May 8 - 9, 2024 | Atlanta

2nd Health Equity in Clinical Trials Congress | 2024 | Atlanta

Receive case-studies, data-driven approaches and best practices to create diversity, equity, and inclusion action

DOWNLOAD THE PROGRAM
ATLANTA
8-9 May, 2024

“In my opinion, this Congress brought the right people together, with the right size, with the right spirit, with the right format. It was educational and the networking was truly incredible ”

Michel Reid, Senior Director & Head, Global Demographics & Diversity, GSK

The First Dedicated Health Equity Conference Spanning the Clinical Trial Ecosystem

Receive the implementable tools to improve DEI recruitment and retention in clinical trials through case-study panel discussions and presentations.

Understand how to refine your data-driven approach to clinical trial diversity by incorporating real world evidence, technology, and patient communications.

Deliver sustainable community engagement efforts across your clinical trials and expand your collaboration efforts across social and healthcare ecosystems.

Including Smaller Drug Developers

Biotechs and small pharma are often falling behind with diversity in clinical trials, we aim to create collaboration with these companies to ensure health equity is front of mind across the industry.

Industry Accountability & Alignment

Targeting structural and systemic barriers can only be achieved if we hold the entire
system accountable for creating action whilst providing the industry with the solutions to create real change.

Lifting Up All Voices and Communities

From patients to the diversity heads of pharmaceutical giants, we explore
every level of health equity action whilst platforming advocates of all under-served
communities.

AUDIENCE BREAKDOWN

  • Pharmaceutical & Biotech Companies

    This event provides a non-competitive space for leading industry companies to platform their health equity strategy successes and discuss the next steps needed to improve health equity action.

    45%
  • Clinical Trial Service Providers

    Discover the innovations being made to improve health equity action from CROs, AI companies, data analytics companies, alternative care models and medtech companies.

    20%
  • Research Sites & Academic Institutions

    Meet principal investigators and the workforce conducting clinical research, learn how to educate communities and engage with hard-to-reach populations.

    20%
  • Patient Advocacy Groups & Non-Profits

    Discuss the actors required to adapt a patient-centric approach to health equity in clinical trials and implement minority patient voices throughout the entire process.

    12%
  • Regulatory & Government Agencies

    Meet the high-level bodies that influence health equity progression and understand the best practices from the FDA diversity plan submission and post market analyses.

    3%

TRAILBLAZING SPEAKERS

 

Kim Fookes

Global Head, Diversity & Inclusion in Clinical Trials
Novartis

Kim Fookes

Global Head, Diversity & Inclusion in Clinical Trials
Novartis

Kim Fookes

Global Head, Diversity & Inclusion in Clinical Trials
Novartis
 

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer
 

Tabia Henry Akintobi

Associate Dean for Community Engagement, Principal Investigator
Morehouse School of Medicine

Tabia Henry Akintobi

Associate Dean for Community Engagement, Principal Investigator
Morehouse School of Medicine

Tabia Henry Akintobi

Associate Dean for Community Engagement, Principal Investigator
Morehouse School of Medicine
 

Martin Mendoza

Director of Health Equity
National Institute of Health

Martin Mendoza

Director of Health Equity
National Institute of Health

Martin Mendoza

Director of Health Equity
National Institute of Health
 

Rajbir Singh

Principal Investigator
Meharry Medical College

Rajbir Singh

Principal Investigator
Meharry Medical College

Rajbir Singh

Principal Investigator
Meharry Medical College
 

Edie Stringfellow

Vice President of Ecosystem Development
Center for Global Health Innovation

Edie Stringfellow

Vice President of Ecosystem Development
Center for Global Health Innovation

Edie Stringfellow

Vice President of Ecosystem Development
Center for Global Health Innovation
2
Main Event Days
50+
Industry Leading Speakers
350+
Industry Experts
10+
Dedicated Networking Hours

Content Partners

Event Partner

Dinner Host

Media Partners

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Company number: 09316521

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.